Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT03222609

A Phase 2 Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination with Ruxolitinib in Subjects with Myelofibrosis

Status

Open

Conditions

Bones and Joints

Phases

II (Cancer Control)

Age Group

Adult

Main Investiagtor

Norkin, Maxim

Practice

Bone Marrow

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT03222609

Secondary Trial ID Number

M16-109/AbbVie

Keywords

Treatment